Biden’s HHS on ‘Different Page’ About How to Curb Drug Prices

Joe Biden enters the presidency with a slew of lawsuits waiting over Trump-era moves to lower drug prices, an issue the new administration will likely tackle in its own way.

The Department of Health and Human Services under Biden inherits challenges to rules that tie drug reimbursement to cheaper foreign prices and allow medication imports from Canada. It also faces complaints over the Trump administration’s push for drugmakers to send discounted drugs purchased by low-income health centers to commercial contract pharmacies.

The attacks flow from major pharmaceutical companies like Sanofi and AstraZeneca, as well as groups representing a wide ...